Table 4.
Multinomial logistic regression of VAT and SAT gene expression associated with NAFLD.
| Variable | B | S.E. (B) | Exp B (OR) (95% C.I) | Sig. | R2 (%) | Correct Prediction (%) | M. Sig. |
|---|---|---|---|---|---|---|---|
| MODEL 1 | |||||||
| SAT-TGFB1 | 1.397 | 0.642 | 4.04 (1.15–14.23) | 0.030 | 45.2 | 80 | 0.000 |
| VAT-P53 | −1.400 | 0.634 | 0.25 (0.07–0.85) | 0.027 | |||
| Age | −0.016 | 0.040 | 0.98 (0.91–1.06) | 0.683 | |||
| MODEL 2 | |||||||
| SAT-TGFB1 | 110.07 | 8455.23 | 6.33 (0.00–>50.00) | 0.790 | 100 | 100 | 0.000 |
| VAT-P53 | −56.76 | 5653.40 | <0.001 (–) | 0.792 | |||
| VAT-CIDEA | −390.28 | 13264.12 | <0.001 (–) | 0.777 | |||
| SAT-UCP2 | 264.87 | 9103.50 | 10.73 (0.00–>50.00) | 0.777 | |||
| SAT-ATG5 | −54.44 | 2596.91 | <0.001 (–) | 0.783 | |||
| SAT-MRC1 | −97.42 | 7094.69 | <0.001 (–) | 0.789 | |||
| VAT-ANGPT2 | −149.39 | 5819.60 | <0.001 (–) | 0.780 | |||
| Age | 8.92 | 312.56 | 74.90 (0.00–>100.00) | 0.777 | |||
B, Beta coefficient; S.E. (B), Standard error of Beta; Exp B (OR) (95% C.I), Exponent beta with 95% confidence intervals; Sig, p value tested for each independent variable enter in the model; R2, Nagelkerke R Square of the model; Correct prediction (%), Percentage of patients correctly classified for NAFLD according to model; M. Sig, Model significance based on Omnibus test of the model coefficients.